Your browser doesn't support javascript.
loading
Co-grafts of Human Embryonic Stem Cell Derived Retina Organoids and Retinal Pigment Epithelium for Retinal Reconstruction in Immunodeficient Retinal Degenerate Royal College of Surgeons Rats.
Thomas, Biju B; Lin, Bin; Martinez-Camarillo, Juan Carlos; Zhu, Danhong; McLelland, Bryce T; Nistor, Gabriel; Keirstead, Hans S; Humayun, Mark S; Seiler, Magdalene J.
Afiliação
  • Thomas BB; Department of Ophthalmology, USC Roski Eye Institute, University of Southern California, Los Angeles, CA, United States.
  • Lin B; USC Ginsburg Institute for Biomedical Therapeutics, University of Southern California, Los Angeles, CA, United States.
  • Martinez-Camarillo JC; Department of Physical Medicine and Rehabilitation, University of California, Irvine, Irvine, CA, United States.
  • Zhu D; Stem Cell Research Center, University of California, Irvine, Irvine, CA, United States.
  • McLelland BT; Department of Ophthalmology, USC Roski Eye Institute, University of Southern California, Los Angeles, CA, United States.
  • Nistor G; USC Ginsburg Institute for Biomedical Therapeutics, University of Southern California, Los Angeles, CA, United States.
  • Keirstead HS; Department of Ophthalmology, USC Roski Eye Institute, University of Southern California, Los Angeles, CA, United States.
  • Humayun MS; Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
  • Seiler MJ; Department of Physical Medicine and Rehabilitation, University of California, Irvine, Irvine, CA, United States.
Front Neurosci ; 15: 752958, 2021.
Article em En | MEDLINE | ID: mdl-34764853
End-stage age-related macular degeneration (AMD) and retinitis pigmentosa (RP) are two major retinal degenerative (RD) conditions that result in irreversible vision loss. Permanent eye damage can also occur in battlefields or due to accidents. This suggests there is an unmet need for developing effective strategies for treating permanent retinal damages. In previous studies, co-grafted sheets of fetal retina with its retinal pigment epithelium (RPE) have demonstrated vision improvement in rat retinal disease models and in patients, but this has not yet been attempted with stem-cell derived tissue. Here we demonstrate a cellular therapy for irreversible retinal eye injuries using a "total retina patch" consisting of retinal photoreceptor progenitor sheets and healthy RPE cells on an artificial Bruch's membrane (BM). For this, retina organoids (ROs) (cultured in suspension) and polarized RPE sheets (cultured on an ultrathin parylene substrate) were made into a co-graft using bio-adhesives [gelatin, growth factor-reduced matrigel, and medium viscosity (MVG) alginate]. In vivo transplantation experiments were conducted in immunodeficient Royal College of Surgeons (RCS) rats at advanced stages of retinal degeneration. Structural reconstruction of the severely damaged retina was observed based on histological assessments and optical coherence tomography (OCT) imaging. Visual functional assessments were conducted by optokinetic behavioral testing and superior colliculus electrophysiology. Long-term survival of the co-graft in the rat subretinal space and improvement in visual function were observed. Immunohistochemistry showed that co-grafts grew, generated new photoreceptors and developed neuronal processes that were integrated into the host retina. This novel approach can be considered as a new therapy for complete replacement of a degenerated retina.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article